169 related articles for article (PubMed ID: 20841390)
1. Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.
Levine AJ; Grau MV; Mott LA; Ueland PM; Baron JA
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2541-8. PubMed ID: 20841390
[TBL] [Abstract][Full Text] [Related]
2. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
Figueiredo JC; Levine AJ; Grau MV; Midttun O; Ueland PM; Ahnen DJ; Barry EL; Tsang S; Munroe D; Ali I; Haile RW; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2136-45. PubMed ID: 18708408
[TBL] [Abstract][Full Text] [Related]
3. MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.
Levine AJ; Wallace K; Tsang S; Haile RW; Saibil F; Ahnen D; Cole BF; Barry EL; Munroe DJ; Ali IU; Ueland P; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2409-15. PubMed ID: 18768511
[TBL] [Abstract][Full Text] [Related]
4. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence.
Martínez ME; Giovannucci E; Jiang R; Henning SM; Jacobs ET; Thompson P; Smith-Warner SA; Alberts DS
Int J Cancer; 2006 Sep; 119(6):1440-6. PubMed ID: 16615116
[TBL] [Abstract][Full Text] [Related]
5.
Huang X; Qin X; Yang W; Liu L; Jiang C; Zhang X; Jiang S; Bao H; Su H; Li P; He M; Song Y; Zhao M; Yin D; Wang Y; Zhang Y; Li J; Yang R; Wu Y; Hong K; Wu Q; Chen Y; Sun N; Li X; Tang G; Wang B; Cai Y; Hou FF; Huo Y; Wang H; Wang X; Cheng X
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):679-685. PubMed ID: 29371246
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
[TBL] [Abstract][Full Text] [Related]
7. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
[TBL] [Abstract][Full Text] [Related]
8. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
Martínez ME; Thompson P; Jacobs ET; Giovannucci E; Jiang R; Klimecki W; Alberts DS
Gastroenterology; 2006 Dec; 131(6):1706-16. PubMed ID: 17087956
[TBL] [Abstract][Full Text] [Related]
9. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence.
Martínez ME; Henning SM; Alberts DS
Am J Clin Nutr; 2004 Apr; 79(4):691-7. PubMed ID: 15051616
[TBL] [Abstract][Full Text] [Related]
10. Genetic and environmental determinants of plasma total homocysteine levels: impact of population-wide folate fortification.
Nagele P; Meissner K; Francis A; Födinger M; Saccone NL
Pharmacogenet Genomics; 2011 Jul; 21(7):426-31. PubMed ID: 21597397
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
[TBL] [Abstract][Full Text] [Related]
12. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
[TBL] [Abstract][Full Text] [Related]
13. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province, China.
Ni J; Zhang L; Zhou T; Xu WJ; Xue JL; Cao N; Wang X
J Chin Med Assoc; 2017 Mar; 80(3):147-153. PubMed ID: 28094233
[TBL] [Abstract][Full Text] [Related]
14. Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study.
Hickling S; Hung J; Knuiman M; Jamrozik K; McQuillan B; Beilby J; Thompson P
J Epidemiol Community Health; 2005 May; 59(5):371-6. PubMed ID: 15831684
[TBL] [Abstract][Full Text] [Related]
15. 5,10-Methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations are genetic determinants of elevated homocysteine.
Castro R; Rivera I; Ravasco P; Jakobs C; Blom HJ; Camilo ME; de Almeida IT
QJM; 2003 Apr; 96(4):297-303. PubMed ID: 12651974
[TBL] [Abstract][Full Text] [Related]
16. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals.
Ozarda Y; Sucu DK; Hizli B; Aslan D
Cell Biochem Funct; 2009 Dec; 27(8):568-77. PubMed ID: 19764044
[TBL] [Abstract][Full Text] [Related]
17. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.
Moat SJ; Ashfield-Watt PA; Powers HJ; Newcombe RG; McDowell IF
Clin Chem; 2003 Feb; 49(2):295-302. PubMed ID: 12560354
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term low-dose folic acid supplementation on degree of total homocysteine-lowering: major effect modifiers.
Wang B; Wu H; Li Y; Ban Q; Huang X; Chen L; Li J; Zhang Y; Cui Y; He M; Tang G; Yin D; Li J; Huo Y; Qin X; Xu X
Br J Nutr; 2018 Nov; 120(10):1122-1130. PubMed ID: 30401001
[TBL] [Abstract][Full Text] [Related]
19. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
